Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, Susanne K., May, Jan-Niklas, Theek, Benjamin, Appold, Lia, Drude, Natascha, Kiessling, Fabian, Lammers, Twan·2018·Advanced Drug Delivery Reviews

Cites (227)

Items 201–226 of 226

  1. Core-shell nanocarriers with high paclitaxel loading for passive and active targeting
    Jin Zhu, Yaqi Lv, Hui Cao, Jing Yao, Jianping Zhou, Wei He, Lifang Yin · 2016 · Scientific Reports
  2. Photodetection with 5-Aminolevulinic acid-induced protoporphyrin IX in the rat abdominal cavity: drug-dose-dependent fluorescence kinetics
    Krieg · 2000 · Pure Amsterdam UMC
  3. A Robust Approach to Enhance Tumor-selective Accumulation of Nanoparticles
    Yuan Qiao, Xin Huang, Sridhar Nimmagadda, Ren-Yuan Bai, Verena Staedtke, Catherine A. Foss, Ian Cheong, Matthias Holdhoff, Yoshinori Katō, Martin G. Pomper et al. · 2011 · Oncotarget
  4. Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride
    Katsuyoshi Hori, Sachiko Saito, Hiroto Takahashi, Haruhiko Sato, Hiroshi Maeda, Yasufumi Sato · 2000 · Japanese Journal of Cancer Research
  5. RFA plus lyso-thermosensitive liposomal doxorubicin: in search of the optimal approach to cure intermediate-size hepatocellular carcinoma
    Riccardo Antonio Lencioni, Dania Cioni · 2016 · Hepatic Oncology
  6. Lessons from immuno-oncology: a new era for cancer nanomedicine?
    Wen Jiang, Hengfeng Yuan, Charles K. F. Chan, Christina A. Von Roemeling, Zuoqin Yan, Irving L. Weissman, Betty Y.S. Kim · 2017 · Nature Reviews Drug Discovery
  7. The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
    Daisuke Kudo, Akiko Suto, Kenichi Hakamada · 2017 · International Journal of Molecular Sciences
  8. Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models
    Einar Sulheim, Jana Kim, Annemieke J.E.T. van Wamel, Eugene Kim, Sofie Snipstad, Igor Vidić, Ingeborg Hovde Grimstad, Marius Widerøe, SVERRE HELGE TORP, Steinar Lundgren et al. · 2018 · Journal of Controlled Release
  9. Integration of Nano drug-delivery System With Cancer Immunotherapy
    Takashi Nakamura, Hideyoshi Harashima · 2017 · Therapeutic Delivery
  10. Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion
    Dennis Doleschel, Anne Rix, Susanne Arns, Karin Palmowski, Felix Gremse, Ruth Merkle, Florian Salopiata, Ursula Klingmüller, Michael Jarsch, Fabian M. Kiessling et al. · 2015 · Theranostics
  11. A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)
    Gerald Batist, M. B. Sawyer, N. Gabrail, N. Christiansen, J. L. Marshall, David Robert Spigel, Arthur Chin Louie · 2008 · Journal of Clinical Oncology
  12. Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells
    Haifa Shen, Tong Sun, Hanh H. Hoang, Jana S. Burchfield, Gillian F. Hamilton, Elizabeth Ann Mittendorf, Mauro Ferrari B · 2017 · Seminars in Immunology
  13. Tumor-Targeted Macromolecular Drug Delivery Based on the Enhanced Permeability and Retention Effect in Solid Tumor
    Takahiro Seki, Jun Qun Fang, Hiroshi Maeda · 2009 · Springer eBooks
  14. Quantification of transient increase of the blood–brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles
    Bingmei M. Fu, Lingyan Shi, Paolo Palacio-Mancheno, Joseph V. Badami, Da Wi Shin, Min Zeng, Luís Cardoso, Raymond S. Tu · 2014 · International Journal of Nanomedicine
  15. Possible involvement of p21/waf1 in the growth inhibition of HepG2 cells induced by hepatocyte growth factor
    Nobuyuki Shima, Donna Beer Stolz, Masahiro Miyazaki, Eiichi Gohda, Kanji Higashio, George K. Michalopoulos · 1998 · Journal of Cellular Physiology
  16. Thermosensitive nanomedicines could revolutionize thermal therapy in oncology
    Michael Dunne, Kullervo Hynynen, Christine J. Allen · 2017 · Nano Today
  17. Modified gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer (MPC): A single-institution experience.
    Kavya Krishna, Marlo A. Blazer, Lai Wei, Daniel H. Ahn, Christina Sing-Ying Wu, Kristen Keon Ciombor, Sameh Mikhail, Anne M. Noonan, Richard M. Goldberg, Tanios Bekaii‐Saab · 2015 · Journal of Clinical Oncology
  18. Organoids reveal cancer dynamics
    Calvin Jay Kuo, Christina N. Curtis · 2018 · Nature
  19. Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models
    Andrew T. Lucas, Taylor F. White, Allison Mary Deal, Leah B. Herity, Gina K. Song, Charlene Santos, William C. Zamboni · 2016 · Nanomedicine Nanotechnology Biology and Medicine
  20. Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat Dunning prostate tumor R3327-AT1 following treatment with radiation and/or hyperthermia.
    Peter Peschke, V. A. Klein, Gerd Wolber, E Friedrich, Eric W. Hahn · 1999 · PubMed
  21. Cancer research with a human touch
    Mike May · 2018 · Nature
  22. Erratum: Cancer nanomedicine: is targeting our target?
    Twan Lammers, Fabian M. Kiessling, Marianne B. Ashford, Wim E. Hennink, Daan J.A. Crommelin, Gert Storm · 2016 · Nature Reviews Materials
  23. Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma
    Mark W. Dewhirst, David G. Kirsch · 2018 · JAMA Oncology
  24. Tumor Vasculature, EPR Effect, and Anticancer Nanomedicine: Connecting the Dots
    Sébastien Taurin, Hayley L. Nehoff, Thalita van Aswegen, Khaled F. Greish · 2013 · Springer eBooks
  25. Angiotensin‐Induced Hypertension Chemotherapy in Children with Advanced Solid Tumors
    Yuji Fujii, Teruaki Hongo, Hiroyuki Masui, Takako Chiba, Nobuko Furukawa, Hiroaki Nakajima, Kaoru Nasuda, Shuhei Yajima, Yasuo Horikoshi, Yoshio Igarashi · 1991 · Pediatrics International
  26. Carlos Fernández-del Castillo Confronts The Challenge of Pancreatic Cancer: Although Progress Has Been Slow, a Renowned Expert On the Disease Sees Reasons for Hope.
    Jack McCain · 2014 · PubMed